Gangothri Selvarajan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Chemotherapy Induced

Top Venues

JCO global oncology

South Asian journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Venkatraman Radhakrishnan, Kritthivasan Venkatakrishnan, Jayachandran Perumal Kalaiyarasi, Gangothri Selvarajan, Nizamudin Mahaboobasha, Paulson Vijaykumar Victor, Malarvizhi Anbazhagan, Deyva Manohari Sivanandam, Swaminathan Rajaram
Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study). JCO global oncology 10 (2024)
Venkatraman Radhakrishnan, Kritthivasan Venkatakrishnan, Jayachandran Perumal Kalaiyarasi, Gangothri Selvarajan, Nizamudin Mahaboobasha, Paulson Vijaykumar Victor, Malarvizhi Anbazhagan, Deyva Manohari Sivanandam, Swaminathan Rajaram
Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study). JCO global oncology 10 (2024)
Venkatraman Radhakrishnan, Kritthivasan Venkatakrishnan, Jayachandran Perumal Kalaiyarasi, Gangothri Selvarajan, Nizamudin Mahaboobasha, Paulson Vijaykumar Victor, Malarvizhi Anbazhagan, Deyva Manohari Sivanandam, Swaminathan Rajaram
Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study). JCO global oncology 10 (2024)
Parathan Karunakaran, Gangothri Selvarajan, Jayachandran Perumal Kalaiyarasi, Nikita Mehra, Shirley Sundersingh, Manikandan Dhanushkodi, Sivasree Kesana, Krishnarathinam Kannan, Trivadi S Ganesan, Venkatraman Radhakrishnan, Tenali Gnana Sagar
Therapeutic Outcomes in High-Grade B-Cell Lymphoma, NOS: Retrospective Analysis. South Asian journal of cancer 11 (1) (2022)